Clinical Trial: A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812117) titled 'A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)' on Jan. 31.

Brief Summary: This study will evaluate the safety and effectiveness of mirogabalin in adult patients with diabetic peripheral neuropathic pain (DPNP) in real-world clinical practice setting in China.

Study Start Date: June 27, 2025

Study Type: OBSERVATIONAL

Condition: Diabetic Peripheral Neuropathic Pain

Intervention: OTHER: No Drug

This is an non-interventional, observational study. No drug will be provided or administ...